RVT Journal Quiz: Volume 47, Issue 1, Article 2 – Cutaneous Lymphoma

RVT Journal Quiz: Volume 47, Issue 1, Article 2 – Cutaneous Lymphoma

Continuing to learn after achieving RVT status is essential for the individual and the advancement of the profession. RVTs can earn one (1) Continuing Education (CE) credit by reading the CE articles in the RVT Journal, or watching recorded sessions of OAVT presentations, and submitting the successfully completed corresponding quizzes.

If you obtain a score of 8 out of 10 (80%) or higher, you will receive a confirmation email which OAVT members can use as acceptable proof for their online CE record.

Name
Name
First
Last
1. A patient with stage II multicentric lymphoma would involve which of the following? *
2. Large cell lymphoma is slower to progress than small cell lymphoma. *
3. The gold standard treatment for multicentric lymphoma is a combination of drugs known by the acronym: *
4. Lymphoma can present in which of the following organs of the body? *
5. Mycosis Fungoides (a rare skin cancer affecting people) is most like which of the following? *
6. Definitive diagnosis for cutaneous lymphoma can be made via: *
7. Chronic administration of lomustine can lead to which of the following laboratory abnormalities? *
8. The most significant risk associated with L-asparaginase is: *
9. Which organ of the body is affected by cumulative doses of doxorubicin? *
10. First line therapy for most forms of cutaneous lymphoma is typically achieved via which of the following? *